-
公开(公告)号:USRE49931E1
公开(公告)日:2024-04-23
申请号:US17584147
申请日:2022-01-25
Applicant: Bristol-Myers Squibb Company
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar
IPC: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
CPC classification number: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
Abstract: Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:USRE49880E1
公开(公告)日:2024-03-26
申请号:US17584139
申请日:2022-01-25
Applicant: Bristol-Myers Squibb Company
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Ramesh Kumar Sistla
IPC: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
CPC classification number: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
Abstract: Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:US11820768B2
公开(公告)日:2023-11-21
申请号:US17245595
申请日:2021-04-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC: C07D471/04 , A61K31/437 , C07D491/107 , C07D471/08 , A61P25/00 , A61P29/00 , A61P19/02 , C07D495/10 , C07D519/00 , A61P37/00
CPC classification number: C07D471/04 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , C07D471/08 , C07D491/107 , C07D495/10 , C07D519/00
Abstract: Disclosed are compounds of Formula (I)
N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:US11672780B2
公开(公告)日:2023-06-13
申请号:US17113495
申请日:2020-12-07
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
IPC: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D471/04 , C07D249/00
CPC classification number: A61K31/4196 , A61K31/437 , A61K31/4427 , A61K45/06 , C07D249/00 , C07D471/04
Abstract: Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.-
公开(公告)号:US20230117470A1
公开(公告)日:2023-04-20
申请号:US17773425
申请日:2020-10-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Laxman Pasunoori , Sreekantha Ratna Kumar , Pitani Veera Venkata Srinivas , Vikram Bhogadi , Duraisamy Kunchithapatham Srinivasan , Anupama Kandhi Ramachandra Reddy , Rushith Kumar Anumula , Alaric J. Dyckman
IPC: C07D471/04 , C07D519/00 , C07D417/14
Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and R5 are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11299501B2
公开(公告)日:2022-04-12
申请号:US16955108
申请日:2018-12-18
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Brian K. Whiteley , Sreekantha Ratna Kumar , Anupama Kandhi Ramachandra Reddy
IPC: C07D519/00 , C07D487/04
Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, X, Y, Z, R1, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US11053244B1
公开(公告)日:2021-07-06
申请号:US16910101
申请日:2020-06-24
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC: C07D471/04 , A61K31/437 , C07D491/107 , C07D471/08 , A61P25/00 , A61P37/00 , A61P19/02 , C07D495/10 , C07D519/00 , A61P29/00
Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
公开(公告)号:US20210147361A1
公开(公告)日:2021-05-20
申请号:US16636662
申请日:2018-08-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Ling Li , T.G. Murali Dhar , Hai-Yun Xiao
IPC: C07D213/53 , C07D207/12 , C07D211/40 , C07D211/96 , A61P37/06
Abstract: Disclosed are compounds of Formula (I): (I) or a salt thereof, wherein: X is CH or N; Y is CH or N; R1 is —OH or —OP(O)(OH)2; L1 is —CR3═N—O—CRaRa— or CRaR—O—N═CR3; L2 is a bond, —C(O)—, or S(O)2—; and R2, R3, Ra, m, and n are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
-
公开(公告)号:US20210147357A1
公开(公告)日:2021-05-20
申请号:US16636670
申请日:2018-08-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Ling Li , John L. Gilmore
IPC: C07D207/16
Abstract: Disclosed are compounds of Formula (I): (I) or a salt thereof, wherein: X is —CH2— or —C(O)—; R1 is —OH or —OP(O)(OH)2; L is a bond, —CH2—, or —C(O)—; R2 is n-C6-8 alkyl; each R3 is independently selected from Cl and —CH3; and n is zero, 1, or 2; provided that if X is —CH2—, then L is —CH2— or —C(O)—. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor SlP1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
-
公开(公告)号:US10730877B2
公开(公告)日:2020-08-04
申请号:US16695303
申请日:2019-11-26
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Christopher P. Mussari , Trevor C. Sherwood , Brian K. Whiteley , John L. Gilmore , Sreekantha Ratna Kumar , Laxman Pasunoori , Pitani Veera Venkata Srinivas , Srinivasan Kunchithapatham Duraisamy , Subramanya Hegde , Rushith Kumar Anumula
IPC: C07D471/04 , A61K31/437 , C07D491/107 , C07D471/08 , A61P25/00 , A61P37/00 , A61P19/02 , C07D495/10 , C07D519/00 , A61P29/00
Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
-
-
-
-
-
-
-
-
-